Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
glwl-01 (2 trials)
Diabetes Mellitus, Type 2 (Phase 1)
Prader-Willi Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (2 total)
Trial APIs (1 total)